Risk assessment in deferred and recovered donors

Area of Science:

• Transplantation Science
• Public Health
• Medical Forensics

Background:

• Tissue transplantation is a common and safe procedure, with over 1.75 million transplants annually.
• Donor Risk Assessment Interview (DRAI) and serologic testing are key safety measures.

Purpose of the Study:

• To evaluate the effectiveness of DRAI screening in a medical examiner population.
• To compare DRAI screening with serologic testing for identifying suitable tissue donors.

Main Methods:

• The study analyzed 188 potential donor cases from a metropolitan medical examiner's office.
• Serologic testing results of deferred donors were compared against DRAI screening outcomes.

Main Results:

• DRAI screening successfully deferred most, but not all, serologically reactive donors.
• In 65 cases, DRAI identified serologically reactive donors post-recovery.

Conclusions:

• DRAI screening is a valuable tool but has limitations in identifying all reactive donors.
• A combined approach of DRAI screening and serologic testing is essential for ensuring tissue transplantation safety.